TrialBMJ open2015

Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial.

Clara Rosso-Fernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.